Page 63 - Coronavirus Vaccine

Delhi logs 1,009 new Covid cases, makes facemasks must again in public

Authorities have been asked to keep a close watch on social gatherings and ramp up testing in the national capital.

Covid-19: Delhi sees 1,009 fresh cases, 1 death; positivity rate 5.7%

This was the maximum number of cases recorded in Delhi since February 10 when 1,104 infections were reported

Maharashtra records 162 new Covid cases, zero death; active tally at 690

On Tuesday, the state recorded 137 coronavirus cases and three deaths linked to the disease.

India's R-value, used to track Covid, crosses worrying mark: Researcher

India's effective reproduction number for Covid, an indicator of how quickly the infection is spreading, has increased to over one for first time since January, estimates researcher

No plan to impose fine for not wearing face masks in Delhi: Manish Sisodia

The government is not planning to impose a fine for not wearing face masks in Delhi, Deputy Chief Minister Manish Sisodia said on Tuesday.

Global coronavirus update: Total Covid caseload tops 505.8 million

The global coronavirus caseload has topped 505.8 million, while the deaths have surged to more than 6.20 million and vaccinations to over 11.19 billion, according to Johns Hopkins University

Covid LIVE: Centre writes to UP, Delhi, 3 other states over rising TPR

India recorded 1,247 new Covid infections on Monday; number of active cases rose to 11,860

Johnson & Johnson suspends its Covid-19 vaccine sales forecasts

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as USD 3.5 billion this year. The health care giant said Tuesday that a global supply surplus and demand uncertainty prompted the move, which will not affect the company's operational earnings per share guidance. J&J's one-shot vaccine brought in USD 457 million in global sales during the first quarter, with most of that coming from outside the United States. The vaccine brought in only USD 75 million in sales in the US, or about 25 per cent less than what it rang up after debuting in last year's first quarter. J&J has said it doesn't intend to profit from the vaccine. But it said in January that it could bring in between USD 3 billion and USD 3.5 billion in sales this year, as countries continue to fight variants of the virus. The vaccine brought in USD 2.38 billion in sales last year. Vaccine options from rival drugmakers Pfizer and ...

Kerala govt rejects reports that it didn't give daily Covid data to Centre

Health Minister Veena George said the digital evidences could not be covered up

IPL 2022: DC-PBKS match shifted to Mumbai from Pune after Covid outbreak

The IPL match between COVID-hit Delhi Capitals and Punjab Kings was on Tuesday shifted to Mumbai from Pune following a virus outbreak in the Risabh Pant-led team.

Japan approves fourth Covid-19 vaccine Novavax; jabs expected by late May

The ministry approval comes the day after its experts panel endorsed use of Novavax's protein vaccine, which is designed with similar technology used to fight diseases such as the flu and hepatitis B

Covid: UP govt makes wearing of mask compulsory in 6 NCR districts, Lucknow

In the last 24 hours, 65 new Covid cases have been confirmed in Gautam Buddh Nagar, 20 in Ghaziabad and 10 in Lucknow

Centre turns the heat on Kerala, asks state to update Covid numbers daily

State had stopped daily updates on infections; once numbers eventually became known, country reported 90% spike in fresh cases, 165% surge in positivity rate the past 24 hours

Ocugen to commercialise Covaxin in Mexico, working on US market too

Covaxin has EUA in Mexico for use in adults; data submitted for EUA for children aged 2-18 years

Omicron more likely to cause upper airway infections among children: Report

The higly transmissible variant is known to cause lower severity disease than the Delta variant, the researchers noted

Delhi records 461 new cases of Covid-19 and 2 deaths from disease

Despite less number of tests, the positivity rate jumped high and went beyond 5 per cent on Saturday

'Warm' vaccine candidate effective against Delta, Omicron variants in mice

The vaccine candidate, by the Indian Institute of Science (IISc) in Bengaluru and biotech start-up company Mynvax, uses a part of the viral spike protein called the receptor-binding domain (RBD)

India's cumulative COVID-19 vaccination coverage exceeds 1.86 billion mark

Union Ministry of Health and Family Welfare informed that India's cumulative Coronavirus vaccination coverage crossed 186.38 crores on Saturday, as per the provisional reports by 7 am.

China reports 3,867 new local Covid-19 cases in past 24 hours

Notably, of these new local cases, 3,590 were reported in Shanghai

India records 975 fresh Covid-19 infections, 4 more fatalities

The active cases comprise 0.03 per cent of the total infections